Heart failure & cardiomyopathies
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
An erratum to this article was published (J Am Coll Cardiol, 29 Oct 2024 ↗)
Methodological detailsLiterature search September 14, 2022, to November 22, 2022 (PubMed, EMBASE, Cochrane Library, AHRQ, other databases); additional studies through May 23, 2023, considered
- Literature search September 14, 2022, to November 22, 2022 (PubMed, EMBASE, Cochrane Library, AHRQ, other databases); additional studies through May 23, 2023, considered
Scope
As issued by the authors
Management of patients with hypertrophic cardiomyopathy; updates the 2020 AHA/ACC guideline with new evidence
Original publication
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. Published 8 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →